Delivery Order SPE2DB22D9309-SPE2DB25FAF36
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,510.63 by the Defense Logistics Agency on July 24, 2025, for the supply of Exparel 266 mg/20 ml vials. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a discrete purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 19, 2025, by the Defense Logistics Agency (DLA) for Exparel 133 mg/10 mL vials. The contract, valued at $6,028.88, represents a firm fixed-price delivery order with an ultimate completion date of September 10, 2025. This award was executed without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $37,659.45 for the supply of EXPAREL 266 mg/20 mL vials. The award, made on August 25, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,063.78 by the Defense Logistics Agency on July 25, 2025, for the supply of EXPAREL 266 mg/20 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and carries no set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 11, 2025, by the Defense Logistics Agency (DLA) for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, valued at $7,531.89 with an ultimate completion date of September 2, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $30,127.56 by the Defense Logistics Agency (DLA) on August 18, 2025. The contract calls for the delivery of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials, a long-acting local anesthetic commonly used in surgical and post-operative pain management. This firm fixed-price delivery order, with an ultimate completion date of September 9,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,021.26 by the Defense Logistics Agency (DLA) on July 24, 2025, with an ultimate completion date of August 14, 2025. The delivery order is for EXPAREL 266 mg/20 ml vials, a local anesthetic medication used in surgical and pain management applications. This award was issued without a set-aside designation, allowing the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $10,042.52 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025. The delivery order calls for the supply of EXPAREL 1.3% in 20 milliliter vials, with a quantity of 10 units. The award carries an ultimate completion date of September 16, 2025, and no set-aside designation was utilized in this procurement...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,021.26 by the Defense Logistics Agency (DLA) on August 25, 2025. The contract calls for the delivery of EXPAREL 266 mg/20 ml vials, a local anesthetic used in surgical and pain management applications. The award was issued without set-aside designation, and performance is scheduled for completion by September 16, 2025,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $30,127.56 by the Defense Logistics Agency on August 20, 2025. The contract calls for the delivery of Exparel 266 mg/20 ml vials, a liposomal bupivacaine formulation used for post-operative pain management. The award carries no set-aside designation, and performance is scheduled for completion by September 11, 2025, with...
- SPE2DB22D9309Indefinite Delivery Contract
- SPE2DB22D9309-SPE2DB25FAF36Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,479.40 by the Defense Logistics Agency (DLA) on August 25, 2025. The delivery order, which carries no set-aside designation, covers the supply of Exparel 266 mg/20 mL vials with an ultimate completion date of September 16, 2025. Exparel is a long-acting local anesthetic used in surgical and pain management applications. The contract represents a discrete delivery order issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical items supporting military healthcare facilities worldwide. This award reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain. The company has consistently secured delivery orders from the DLA covering an extensive portfolio of medications and medical consumables, including prescription drugs, biologics, and specialty pharmaceuticals serving Department of Defense healthcare sites. The firm fixed-price structure and the relatively modest contract ceiling value are typical of individual delivery orders issued under the larger IDC vehicle, allowing the DLA to efficiently procure specific pharmaceutical products as needed to support military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 8/25/25 |